Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in interests of the under-mentioned Persons Discharging Managerial Responsibility in the Ordinary shares of GlaxoSmithKline plc ("Ordinary shares") following the vesting of 50% of awards made under the GlaxoSmithKline Deferred Investment Award Plan ("the Plan") on 18 September 2007:
Ms C Thomas |
Following the vesting of 5,850.558 Ordinary shares under the Plan on 18 September 2011, Ms Thomas will receive a payment of 1302.50 pence per Ordinary share on 20 October 2011. |
Mr D Redfern
|
Following the vesting of 9,360.893 Ordinary shares under the Plan on 18 September 2011, Mr Redfern will receive a payment of 1302.50 pence per Ordinary share on 20 October 2011. |
The Company and the above-mentioned persons were advised of this information by the Administrators of the Plan on 22 September 2011.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
22 September 2011